Brokers name 3 ASX shares to buy

Brokers have named these ASX shares as buys…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

With the majority of brokers across Australia taking a well-earned break, broker notes are few and far between at present.

In light of this, listed below are a few recent broker recommendations that remain very relevant today. Here are three ASX shares rated as buys:

A man with a wide, eager smile on his face holds up three fingers.

Image source: Getty Images

BHP Group Ltd (ASX: BHP)

According to a note out of Macquarie, its analysts have retained their outperform rating and $52.00 price target on this mining giant's shares. Macquarie highlights that industry data appears to indicate improving demand for iron ore. In addition, the broker notes that BHP remains it top pick among the major miners. It estimates that the company's shares are trading on a free cash flow yield in the high teens, which bodes well for dividends. The BHP share price is trading at $41.47 this afternoon.

NEXTDC Ltd (ASX: NXT)

Another note out of Macquarie reveals that its analysts have retained their outperform rating and $16.10 price target on this data centre operator's shares. This follows news that NEXTDC has acquired its first edge data centre in Maroochydore on the Sunshine Coast. Macquarie sees a big opportunity in edge data centres, which service regional areas and have the potential to offer greater returns than current centres in capital cities. The NEXTDC share price is fetching $12.86 on Friday afternoon.

Qantas Airways Limited (ASX: QAN)

Analysts at Citi have retained their buy rating but trimmed their price target on this airline operator's shares to $5.86. Although Qantas' trading update revealed that it will be posting a big first half loss, Citi remains positive and believes the risk/reward on offer remains attractive. Particularly given how at these levels, the broker thinks the International recovery is not priced into its shares. The Qantas share price is trading at $4.97 today.

Motley Fool contributor James Mickleboro owns NEXTDC Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

Business people discussing project on digital tablet.
Broker Notes

Buy, hold, sell: James Hardie, REA Group, and Ramelius shares

Analysts have given their verdict on these shares.

Read more »

Small kid giving a thumbs up.
Broker Notes

2 ASX 200 stocks that Morgans just upgraded

These stocks have between 15% and 20% upside.

Read more »

A little girl with red hair runs excitedly with a rocket strapped to her back, trying to launch.
Broker Notes

6 ASX 200 shares boosted by brokers this week

Brokers have increased their ratings on CSL, NAB, Ramsay Health Care, and others this week. 

Read more »

I young woman takes a bite out of a burrito n the street outside a Mexican fast-food establishment.
Broker Notes

Buy, hold, sell: Aurizon, Car Group, Guzman y Gomez shares

Toby Grimm from Baker Young explains his views and ratings on three ASX 300 shares.

Read more »

Broker looking at the share price.
Broker Notes

Buy, hold, sell: Temple & Webster, Kelsian, Boss Energy shares

Two experts share their views on three ASX shares.

Read more »

A man in a business suit holds his coffee cup aloft as he throws his head back and laughs heartily.
Broker Notes

3 ASX 200 shares forecast to fly 30% to 40% higher

Here's the latest broker forecasts.

Read more »

A mother and her two adult daughters embrace outdoors.
Broker Notes

Buy, hold, sell: AGL Energy, Telstra, Zip shares

Here are brokers' latest verdicts on these three major ASX 200 shares.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Broker Notes

This ASX biotech could jump more than 30%, one broker says

This company's core business is performing well, the broker says.

Read more »